FDA Inspection 1099394 — Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. — FEI 3002721084

The FDA completed an inspection of Teva Pharmaceutical Industries Ltd. on July 25, 2019 in Kfar Saba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kfar Saba (Israel)